z-logo
Premium
Preliminary evaluation of the toxicity of some synthetic furan derivatives in two cell lines and Artemia salina
Author(s) -
Amaro María I.,
Monasterios Melina,
Avendaño Milagros,
Charris Jaime
Publication year - 2009
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.1379
Subject(s) - artemia salina , brine shrimp , bioassay , toxicity , cytotoxicity , chemistry , nitrofuran , acute toxicity , chromatography , stereochemistry , pharmacology , biochemistry , biology , traditional medicine , organic chemistry , in vitro , medicine , genetics
This study describes the preliminary toxicity evaluation of five new furan derivatives, 2‐[2‐acetylamino‐2‐[(benzothiazolyl‐substituted)aminocarbonyl]vinyl]‐5‐nitro furane (compounds A, B, D and E) and 2‐[2‐phenylamino‐2‐[benzothiazolylaminocarbonyl]vinyl]furane (compound C). Cytotoxicity was determined using the MTT (tetrazolium salt) method over BHK21 (Syrian baby hamster kidney) and Hep‐2 (human larynx carcinoma) cells, which had previously been used to evaluate the cytotoxicity of the 5‐nitrofuran derivatives. The lethal concentration 50 (LC 50 ) was determined using brine shrimp ( Artemia salina ) bioassay. Nitrofurantoin was used as reference compound. The results demonstrate that BHK21 cells are more sensitive than Hep‐2 cells. This structurally related serial of compounds shows a differential toxicity, which is an indication that the toxicity naturally arising from the nitro group can be modulated by the substituents over the furan ring. Additionally, compound C, the only derivative with no nitro group, was least toxic to Hep‐2, but exhibits toxicity to BHK21 cells and brine shrimp. The LC 50 brine shrimp test (BST) bioassay results were as follows: A, 654.2 µg ml −1 ; B, 50.0 µg ml −1 ; C, 533.4 µg ml −1 ; D, 172.1 µg ml −1 ; E, 76.4 µg ml −1 , and NF, >1000 µg ml −1 . Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here